SCHEMBL1961802

SCHEMBL1961802

OC1CC(O)C(O)C1O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12433247 1.00
SCHEMBL18167015 0.95 LMNA (0.46)
SCHEMBL14771462 0.95 LMNA (0.46)
SCHEMBL14542553 0.95 LMNA (0.46)
SCHEMBL6079050 0.95 LMNA (0.46)
SCHEMBL1681800 0.95 LMNA (0.46)
SCHEMBL12679333 0.95 LMNA (0.46)
SCHEMBL5151166 0.95 LMNA (0.46)
SCHEMBL17925160 0.95 LMNA (0.46)
SCHEMBL12858619 0.95 LMNA (0.46)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 49 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12594346-B2 Crosslinked hydrogel for immune checkpoint blockade delivery GEORGIA TECH RESEARCH CORPORATION (US) 2026-04-07 US disclosed
US-20250339581-A1 SYNTHETIC HYDROGEL CARRIERS FOR MUSCLE REPAIR GEORGIA TECH RES INST (US) 2025-11-06 US disclosed
US-12397084-B2 Synthetic hydrogel carriers for muscle repair GEORGIA TECH RESEARCH CORPORATION (US) 2025-08-26 US disclosed
US-20230257463-A1 IN SITU THIOL-MALEIMIDE CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY GEORGIA TECH RESEARCH CORPORATION 2023-08-17 US disclosed
US-20230256115-A1 CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY UNIVERSITY OF LOUISVILLE RESEARCH FOUNDATION, INC. 2023-08-17 US disclosed
EP-4178988-A1 IN SITU THIOL-MALEIMIDE CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY Georgia Tech Research Corporation (US) 2023-05-17 EP disclosed
EP-4178623-A1 CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY Georgia Tech Research Corporation (US) 2023-05-17 EP disclosed
US-11565024-B2 Lysostaphin containing synthetic hydrogel carriers for bone repair GEORGIA TECH RESEARCH CORPORATION (US) 2023-01-31 US disclosed
US-11478571-B2 Synthetic hydrogel carriers for cellular structures, generation of organoids, and treatment of tissue injury GEORGIA TECH RESEARCH CORPORATION (US) 2022-10-25 US disclosed
WO-2022015723-A1 IN SITU THIOL-MALEIMIDE CROSSLINKED HYDROGEL FOR IMMUNE CHECKPOINT BLOCKADE DELIVERY GEORGIA TECH RESEARCH CORPORATION (US) 2022-01-20 WO disclosed
US-5455325-A Optically active phenoxypropionic esters BASF AKTIENGESELLSCHAFT (DE) 1995-10-03 US disclosed
US-5417882-A Data carriers and display elements BASF AKTIENGESELLSCHAFT (DE) 1995-05-23 US disclosed
US-5417884-A Containing a thiadiazole group BASF AKTIENGESELLSCHAFT (DE) 1995-05-23 US disclosed
US-5350873-A Optically active phenoxypropionic esters BASF AKTIENGESELLSCHAFT (DE) 1994-09-27 US disclosed
EP-0583605-A1 Defined oligomeric liquid crystalline compounds with smectic liquid crystalline phases BASF Aktiengesellschaft (DE) 1994-02-23 EP disclosed
EP-0528268-A2 Optically active esters of phenoxypropionic acid BASF Aktiengesellschaft (DE) 1993-02-24 EP disclosed
EP-0504660-A2 Liquid crystal compounds BASF Aktiengesellschaft (DE) 1992-09-23 EP disclosed
US-4210458-A MIXING PREFORMED MOLTEN SULFUR CONCENTRATE WITH MOLTEN SULFUR IN PRESENCE OF SATURATED POLYHYDRIC ALCOHOL CHEVRON RESEARCH COMPANY (US) 1980-07-01 US disclosed
US-4060519-A POLY(OXYALKYLENE)-POLYESTER-POLY(MONOSULFIDE) POLYTHIOL, NAPHTHALENE, CURING PHILLIPS PETROLEUM COMPANY (US) 1977-11-29 US disclosed
US-3931078-A SEALANT AND COATING COMPOSITIONS FROM POLY(OXYALKYLENE)-POLYESTER-POLY(MONOSULFIDE)-POLYTHIOLS, COAL TAR, AND FILLERS PHILLIPS PETROLEUM COMPANY (US) 1976-01-06 US disclosed